Movement Alert|Chewy, Inc. Falls 6.1% in Pre-Market Trading, Q2 Revenue Misses Select Estimates Amid Lowered Full-Year Outlook

Market Focus
Yesterday

On September 9, Chewy, Inc. fell 6.1% in pre-market trading, trading at approximately $21.80 per share, with turnover of $9.64 million. The decline was triggered by the company's fiscal Q2 earnings release, in which revenue fell short of some institutional estimates against a backdrop of previously reduced full-year sales guidance.

Chewy reported fiscal Q2 adjusted earnings of $0.36 per diluted share, up 9.1% year-over-year and in line with consensus. However, net sales of $3.33 billion, while up 7.4% year-over-year, missed certain analyst projections of $3.361 billion. The company had already cut its fiscal 2026 net sales guidance to $13.40–$13.55 billion from $13.60–$13.75 billion following Q1 results, citing a more cautious consumer spending environment. UBS had flagged the Q2 print as a key test for the credibility of management's second-half outlook, noting that weaker premiumization and attach rates could constrain growth to the mid-single-digit range. Options markets had priced in a 16.37% implied move ahead of the report, with the current decline falling within that range. The average analyst rating remains overweight with a mean price target of $31.09.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10